Literature DB >> 16902925

Influence of the scyphostatin side chain on the mode of inhibition of neutral sphingomyelinase.

Veit Wascholowski1, Athanassios Giannis, Emmanuel N Pitsinos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16902925     DOI： 10.1002/cmdc.200600099

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  4 in total

1.  A strategy for the late-stage divergent syntheses of scyphostatin analogues.

Authors:  Jacob Y Cha; G Leslie Burnett; Yaodong Huang; Jarrod B Davidson; Thomas R R Pettus
Journal:  J Org Chem       Date:  2011-01-21       Impact factor: 4.354

2.  Dynamic kinetic resolution during a vinylogous Payne rearrangement: a concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin.

Authors:  Thomas R Hoye; Christopher S Jeffrey; Dorian P Nelson
Journal:  Org Lett       Date:  2010-01-01       Impact factor: 6.005

Review 3.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013

4.  Enriched Expression of Neutral Sphingomyelinase 2 in the Striatum is Essential for Regulation of Lipid Raft Content and Motor Coordination.

Authors:  Laura Hui-Ru Tan; Angela Jin-Rong Tan; Yu-Ying Ng; John Jia-En Chua; Wee-Siong Chew; Sneha Muralidharan; Federico Torta; Bamaprasad Dutta; Siu Kwan Sze; Deron R Herr; Wei-Yi Ong
Journal:  Mol Neurobiol       Date:  2017-10-17       Impact factor: 5.590
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.